A combination of a VEGF receptor antagonist and a histondeacetylase inhibitor is highly antitumoral effective in a rat hepatoma model

被引:0
|
作者
Ganslmayer, M
Zimmermann, A
Ocker, M
Zopf, S
Schuppan, D
Hahn, EG
Herold, C
机构
[1] Univ Erlangen Nurnberg, Dept Med 1, Erlangen, Germany
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:377A / 377A
页数:1
相关论文
共 50 条
  • [41] Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis
    Fujinaga, Yukihisa
    Kawaratani, Hideto
    Kaya, Daisuke
    Tsuji, Yuki
    Ozutsumi, Takahiro
    Furukawa, Masanori
    Kitagawa, Koh
    Sato, Shinya
    Nishimura, Norihisa
    Sawada, Yasuhiko
    Takaya, Hiroaki
    Kaji, Kosuke
    Shimozato, Naotaka
    Moriya, Kei
    Namisaki, Tadashi
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 15
  • [42] Effects of ridogrel, a thromboxane synthase inhibitor and receptor antagonist, on blood pressure in the spontaneously hypertensive rat
    Quest, DW
    Wilson, TW
    JAPANESE JOURNAL OF PHARMACOLOGY, 1998, 78 (04): : 479 - 486
  • [43] Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human AML.
    Bhalla, Kapil N.
    Fiskus, Warren
    Peth, Karissa
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] CORTICOTROPIN-RELEASING HORMONE-RECEPTOR ANTAGONIST IS EFFECTIVE FOR FEBRILE SEIZURES IN THE INFANT RAT
    BARAM, TZ
    SCHULTZ, L
    ANNALS OF NEUROLOGY, 1994, 36 (03) : 487 - 487
  • [45] Effect of an oral endothelin a receptor antagonist in a rat model of diabetic nephropathy.
    Harron, JC
    ORourke, D
    Gardiner, T
    Chakravarthy, U
    Upritchard, ACG
    Maxwell, AP
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A2970 - A2970
  • [46] Effect of a BLT receptor antagonist in a model of severe ischemia and reperfusion injury in the rat
    Souza, DG
    Pinho, V
    Cassali, GD
    Poole, S
    Teixeira, MM
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2002, 440 (01) : 61 - 69
  • [47] Leukotriene receptor antagonist usage in a rat model of acute respiratory distress syndrome
    Abdelkarim, T
    Herndon, B
    CRITICAL CARE MEDICINE, 2001, 29 (12) : A87 - A87
  • [48] Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy
    Hara, H
    Yamada, N
    Kodama, M
    Matsumoto, Y
    Wake, Y
    Kuroda, S
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2006, 531 (1-3) : 59 - 65
  • [49] ACE inhibitor and angiotensin type I receptor antagonist in combination reduce renal damage in obese Zucker rats
    Toblli, JE
    DeRosa, G
    Cao, G
    Piorno, P
    Pagano, P
    KIDNEY INTERNATIONAL, 2004, 65 (06) : 2343 - 2359
  • [50] Combination of an src kinase inhibitor with a novel pharmacological antagonist of the urokinase receptor diminishes in vitro colon cancer invasiveness
    Boyd, DD
    Wang, H
    Avila, H
    Parikh, NU
    Kessler, H
    Magdolen, V
    Gallick, GE
    CLINICAL CANCER RESEARCH, 2004, 10 (04) : 1545 - 1555